Inventor · disambiguated record
Cen Xu
Also filed as: XU CEN
18 granted patents·5 pending applications·109 citations·filing 2009–2024
93Inventor score
Top patents by PatentIndex Score
23 records- 0195US9365653B2Human PAC1 antibodiesAMGEN INC·Filed 2014·Granted Jun 14, 2016·24 cites·27 claims
- 0295US9102731B2Human CGRP receptor binding proteinsBOONE THOMAS C·Filed 2009·Granted Aug 11, 2015·39 cites·15 claims
- 0394US10053507B2Human PAC1 antibodiesAMGEN INC·Filed 2017·Granted Aug 21, 2018·6 cites·19 claims
- 0494US9822178B2Human PAC1 antibodiesAMGEN INC·Filed 2016·Granted Nov 21, 2017·6 cites·29 claims
- 0591US11891435B2Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereofAMGEN INC·Filed 2021·Granted Feb 6, 2024·1 cites·24 claims
- 0691US10822408B2PACAP antibodies and uses thereofAMGEN INC·Filed 2016·Granted Nov 3, 2020·10 cites·23 claims
- 0791US10738110B2PAC1 antibodies and uses thereofAMGEN INC·Filed 2019·Granted Aug 11, 2020·3 cites·17 claims
- 0891US9862771B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2015·Granted Jan 9, 2018·8 cites·36 claims
- 0991US9676851B2Human PAC1 antibodiesAMGEN INC·Filed 2014·Granted Jun 13, 2017·6 cites·20 claims
- 1091US2025129172A1Human cgrp receptor binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 1189US10934362B2Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereofAMGEN INC·Filed 2015·Granted Mar 2, 2021·5 cites·43 claims
- 1285US11248043B2Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereofAMGEN INC·Filed 2020·Granted Feb 15, 2022·1 cites·33 claims
- 1381US2024150448A1Pac1 antibodies and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 1477US12134652B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2020·Granted Nov 5, 2024·0 cites·12 claims
- 1577US12122841B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2020·Granted Oct 22, 2024·0 cites·18 claims
- 1675US10793631B2Human PAC1 antibodiesAMGEN INC·Filed 2019·Granted Oct 6, 2020·0 cites·20 claims
- 1769US10472417B2Human PAC1 antibodiesAMGEN INC·Filed 2018·Granted Nov 12, 2019·0 cites·15 claims
- 1868US10294298B2Human PAC1 antibodiesAMGEN INC·Filed 2017·Granted May 21, 2019·0 cites·19 claims
- 1964US2018142029A1Human cgrp receptor binding proteinsAMGEN INC·Filed 2017·Application pending·0 cites
- 2063US11780914B2PACAP antibodies and uses thereofAMGEN INC·Filed 2020·Granted Oct 10, 2023·0 cites·19 claims
- 2162US11919964B2Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereofAMGEN INC·Filed 2020·Granted Mar 5, 2024·0 cites·33 claims
- 2260US2013071410A1Human CGRP Receptor Binding ProteinsBOONE THOMAS C·Filed 2012·Application pending·0 cites
- 2349US2022363770A1Anti-cgrp receptor/anti-pac1 receptor bispecific antigen binding proteinsAMGEN INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cen Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →